Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Mikhail Hammond"'
Autor:
Fiore Cattaruzza, Ayesha Nazeer, Zachary Lange, Caitlin Koski, Mikhail Hammond, Trang Dao-Pick, Angela Henkensiefken, Mika Derynck, Volker Schellenberger, Bryan Irving
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Externí odkaz:
https://doaj.org/article/251cfc5cf7644032b9a3fd31021d0f8c
Autor:
Fiore Cattaruzza, Ayesha Nazeer, Milton To, Mikhail Hammond, Caitlin Koski, Lucas Y. Liu, V. Pete Yeung, Deena A. Rennerfeldt, Angela Henkensiefken, Michael Fox, Sharon Lam, Kari M. Morrissey, Zachary Lange, Vladimir N. Podust, Mika K. Derynck, Bryan A. Irving, Volker Schellenberger
Publikováno v:
Nature Cancer. 4:485-501
To enhance the therapeutic index of T-cell engagers (TCEs), we engineered masked, precision-activated TCEs (XPAT proteins), targeting a tumor antigen (human epidermal growth factor receptor 2 (HER2) or epidermal growth factor receptor (EGFR)) and CD3
Autor:
Fiore Cattaruzza, Ayesha Nazeer, Milton To, Mikhail Hammond, Caitlin Koski, Lucas Liu, V. Pete Yeung, Deena Rennerfeldt, Angela Henkensiefken, Michael Fox, Sharon Lam, Kari Morrissey, Zachary Lange, Vladimir Podust, Mika Derynck, Bryan Irving, Volker Schellenberger
To enhance the therapeutic index of T-cell engagers (TCE), we engineered masked, conditionally active TCEs (XPAT proteins), targeting a tumor antigen (human epidermal growth factor receptor 2 [HER2] or epidermal growth factor receptor 2 [EGFR]) and C
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e9fbef64ebfb9ce12787efd733daeaf5
https://doi.org/10.21203/rs.3.rs-2045998/v1
https://doi.org/10.21203/rs.3.rs-2045998/v1
Autor:
Yogesh G. Shelke, Kyriacos C. Nicolaou, Aaron Kempema, Balu D. Dherange, Mikhail Hammond, Monette Aujay, Baiwei Lin, Christine Gu, Joseph Sandoval, Julia Gavrilyuk
Publikováno v:
The Journal of Organic Chemistry. 85:2865-2917
Despite previous studies within the epothilone field, only one member of this compound family, ixabepilone, made it to approval for clinical use. Recent advances in organic synthesis and medicinal chemistry allow further optimization of lead epothilo
Autor:
Monette Aujay, Lloyd T. Lam, Joseph Sandoval, Joseph Lyssikatos, Santhosh Reddy Rekula, Ananda Rao Podilapu, Kyriacos C. Nicolaou, Ryan P Matuszak, Paul M. Jung, Julia Gavrilyuk, Andrew C. Phillips, Hetal Sarvaiya, S. Mothish Kumar, Regina M. Reilly, James W. Purcell, Stefan Munneke, Christine Gu, Mikhail Hammond
Publikováno v:
The Journal of organic chemistry. 86(3)
Thailanstatin A and spliceostatin D, two naturally occurring molecules endowed with potent antitumor activities by virtue of their ability to bind and inhibit the function of the spliceosome, and their natural siblings and designed analogues, constit
Autor:
Julia Gavrilyuk, Mikhail Hammond, Subhrajit Rout, Yong Lu, Monette Aujay, Kyriacos C. Nicolaou, Joseph Sandoval, Emmanuel N. Pitsinos, Dipendu Das, Joseph Lyssikatos, Alexander Schammel
Publikováno v:
Journal of the American Chemical Society. 142(5)
The family of anthraquinone-fused enediyne antitumor antibiotics was established by the discovery of dynemicin A and deoxy-dynemicin A. It was then expanded, first by the isolation of uncialamycin, and then by the addition to the family of tiancimyci
Autor:
Milton To, Pete Yeung, Michael Fox, Mikhail Hammond, Fiore Cattaruzza, Ayesha Nazeer, Caitlin Koski, Lucas Liu, Sina Khorsand, Deena Rennerfeldt, Kari Morrissey, Zachary Lange, Ming Dong, Sharon Lam, Mika K. Derynck, Bryan A. Irving, Volker Schellenberger
Publikováno v:
Molecular Cancer Therapeutics. 20:P193-P193
Background: TCEs are effective in leukemias, but have been limited in solid tumors due to on-target, off-tumor toxicity. Attempts to circumvent cytokine release syndrome (CRS), including step-up dosing and complex designs, have had limited success du
Autor:
Zachary Lange, Bryan Irving, Mika K. Derynck, Volker Schellenberger, Caitlin Koski, Sharon Lam, Milton To, Fiore Cattaruzza, Mikhail Hammond, Ayesha Nazeer, Pete Yeung
Publikováno v:
Cancer Research. 81:1824-1824
Background: TCEs are effective in leukemias but have been challenging in solid tumors due to on-target, off-tumor toxicity. Attempts to circumvent cytokine release syndrome (CRS) including step-up dosing and/or complex molecular designs have been uns
Autor:
Mikhail Hammond, Ayesha Nazeer, Trang Dao-Pick, Mika K. Derynck, Caitlin Koski, Zachary Lange, Volker Schellenberger, Fiore Cattaruzza, Angela Henkensiefken, Bryan Irving
Publikováno v:
Cancer Research. 81:PS17-11
Background TCEs are effective at inducing remissions in hematologic cancers but have been challenging in solid tumors due to on-target, off-tumor toxicity. Attempts to circumvent CRS include fractionated or step-up dosing and/or complex molecular des
Autor:
Ayesha Nazeer, Fiore Cattaruzza, Zachary Lange, Angela Henkensiefken, Bryan Irving, Mika K. Derynck, Mikhail Hammond, Volker Schellenberger, Caitlin Koski
Publikováno v:
Cancer Research. 80:3376-3376
Background: TCEs have proven to be effective in creating durable remissions in hematologic malignancies but have been challenging in solid tumors due to on-target, off-tumor toxicity. To circumvent the toxicity, many have tried step-up, fractionated